Allogene Therapeutics Stock (NASDAQ: ALLO)

Allogene Therapeutics

ALLOGENE THERAPEUTICS INC

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

movers image

News

Intraday Update

Markets

Movers

Trading Ideas

ALLO

HEES

INTC

MRNA

OSCR

RXRX

SMCI

ZLAB

Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday

Gene therapy

Biotech

Health Care

General

CABA

KYTX

CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech&#39;s remarkable remission. This breakthrough offers new hope for autoimmune disease patients but faces challenges in cost and manufacturing.

Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges

AGRI

AKAN

AONC

APLD

ATEN

AULT

BDRX

BRSH

CRKN

CSLR

CTNT

DARE

EDBL

FFIE

FWRD

GSX Techedu Inc. American Depositary Shares

GOTU

GWAV

HSAI

ISUN

KEYS

LICN

Larimar Therapeutics, Inc. - Common Stock

LRMR

LUXH

MGOL

MGRX

MMAT

Eaton Vance Massachusetts Municipal Income Trust

NDSN

ONFO

PANW

PEGY

PTON

SCPX

TRNS

WALD

XPEV

XYLO

ZENV

Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics Inc

ALLON THERAPEUTICS INC by Allon Therapeutics Inc.

ALLOVIR INC

Allot Ltd

Press Releases

Allogene Therapeutics Announces Participation in February Investor Conferences

Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology

Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia

Allogene Therapeutics Announces Participation in March Investor Conference

Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update

Earnings

Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update

Allogene Therapeutics Reports First Quarter 2025 Financial Results and Business Update

Amarin Corporation plc - American Depositary Shares

Amarin Corp

Annexon

Astria Therapeutics

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Foghorn Therapeutics

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Genfit

Gossamer Bio

Heron Therapeutics

Immutep Limited - American Depositary Shares

Immutep

Inozyme Pharma

Kodiak Sciences

Monopar Therapeutics

Neurogene

Nuvectis Pharma

Ocugen

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

Solid Biosciences

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Tango Therapeutics

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals

Vanda Pharmaceuticals Inc. - Common Stock

Vanda Pharmaceuticals

Citigroup

Truist Securities

Piper Sandler

RBC Capital

Oppenheimer

Comments

Allogene Therapeutics

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell